Categories Earnings, LATEST, Other Industries
Transocean turns to profit in Q3 on strong revenue growth
Ending a long-drawn losing streak, offshore drilling company Transocean (RIG) Monday reported a profit for the third quarter, defying expectations for a net loss. The rebound was supported by a double-digit increase in revenues. Following the announcement, the company’s stock gained 2% in the after-hours trading.
The Switzerland-based petroleum explorer having its US headquarters in Houston reported a net income of $30 million or $0.06 per share for the third quarter, on an adjusted basis. Analysts had expected a loss of $0.10 per share. On a reported basis, the company posted a loss of $0.88 per share for the three-month period.
The Switzerland-based petroleum explorer reported a net income of $30 million or $0.06 per share for the third quarter
At $816 billion, total contract drilling revenues were 17% higher compared to last year. The top line also came in above analysts’ forecast. During the quarter, the company’s main growth driver was its robust floater contracting activity. Revenue efficiency was 95.2%.
“Consistent with our objective of protecting near-term liquidity, last week we successfully issued $750 million of seven-year priority guaranteed notes replacing the committed Ocean Rig acquisition financing with permanent financing,” said Transocean CFO Mark Mey.
In the September quarter, the management entered into an agreement to acquire submersible rig operator Ocean Rig, as part of its efforts to high-grading the fleet. The deal will be closed by year-end after obtaining shareholders’ approval at the extraordinary general meeting to be held next month.
Transocean shares, which lost about 2% over the past twelve months, traded lower during Monday’s regular session. The stock gained 2% during the extended session following the earnings report.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on